TI
HAE icon

Tidal Investments’s Haemonetics HAE Stock Holding History

Tidal Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
17,840
+3,501
+24% +$228K ﹤0.01% 1471
2025
Q4 		$1.15M Sell
14,339
-1,355
-9% -$91K ﹤0.01% 1198
2025
Q3 		$765K Buy
15,694
+500
+3% +$30.9K ﹤0.01% 1343
2025
Q2 		$1.13M Buy
15,194
+6,408
+73% +$424K 0.01% 980
2025
Q1 		$558K Sell
8,786
-369
-4% -$25.1K ﹤0.01% 1267
2024
Q4 		$715K Sell
9,155
-93
-1% -$7.47K 0.01% 1185
2024
Q3 		$743K Sell
9,248
-52
-0.6% -$4.2K 0.01% 1167
2024
Q2 		$769K Buy
9,300
+6,941
+294% +$611K 0.01% 1037
2024
Q1 		$201K Sell
2,359
-647
-22% -$50.8K ﹤0.01% 1564
2023
Q4 		$257K Sell
3,006
-1,421
-32% -$123K 0.01% 1241
2023
Q3 		$397K Buy
4,427
+481
+12% +$42.9K 0.01% 952
2023
Q2 		$336K Buy
3,946
+829
+27% +$70.1K 0.01% 991
2023
Q1 		$258K Sell
3,117
-2,525
-45% -$204K 0.01% 1079
2022
Q4 		$444K Buy
5,642
+309
+6% +$24.8K 0.02% 696
2022
Q3 		$395K Sell
5,333
-1,157
-18% -$83.1K 0.02% 641
2022
Q2 		$423K Sell
6,490
-647
-9% -$38.3K 0.02% 651
2022
Q1 		$451K Buy
+7,137
New +$388K 0.01% 693

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tidal Investments's HAE Position: Q1 2026 in Review

Tidal Investments increased its Haemonetics (HAE) stake by 24% in Q1 2026, buying an estimated $228K and bringing the position to 17,840 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Tidal Investments first reported a position in HAE in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.15M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Tidal Investments held 17,840 shares of Haemonetics worth $1.01M as of Q1 2026.
  • Tidal Investments bought 3,501 Haemonetics shares in Q1 2026, an estimated $228K.
  • Haemonetics made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #1471 holding.
  • Tidal Investments first reported a position in Haemonetics in Q1 2022 and has held it in 17 quarters since.
  • Tidal Investments's Haemonetics position peaked at $1.15M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.